DNL.L Share News (DNL)

DNL.L Information

There is currently no data for DNL

UK earnings, trading statements calendar - next 7 days

Tue, 07th Sep 2021 16:25

Wednesday 8 September
Bakkavor Group PLC	Half Year Results
Biffa PLC	Trading Statement
Dunelm Group PLC	Full Year Results
Frontier Developments PLC	Full Year Results
Halfords Group PLC	Trading Statement
Inspecs Group PLC	Half Year Results
Pebble Beach Systems Group PLC	Half Year Results
Tissue Regenix Group PLC	Half Year Results
Thursday 9 September
Burford Capital Ltd	Half Year Results
Capital & Regional PLC	Half Year Results
Computacenter PLC	Half Year Results
Lookers PLC	Half Year Results
Chaarat Gold Holdings Ltd	Half Year Results
Destiny Pharma PLC	Half Year Results
Emis Group PLC	Half Year Results
Funding Circle Holdings PLC	Half Year Results
Genus PLC	Full Year Results
International Public Partnerships Ltd	Half Year Results
Jadestone Energy PLC	Half Year Results
LungLife AI Inc	Half Year Results
Oakley Capital Investments Ltd	Half Year Results
Secure Income REIT PLC	Half Year Results
Spire Healthcare Group PLC	Half Year Results
STV Group PLC	Half Year Results
Wm Morrison Supermarkets PLC	Half Year Results
Friday 10 September
no events scheduled
Monday 13 September
Abcam PLC	Full Year Results
Associated British Foods PLC	Trading Statement
Blackbird PLC	Half Year Results
City of London Investment Group PLC	Full Year Results
Dianomi PLC	Half Year Results
Gaming Realms PLC	Half Year Results
Greencoat Renewables PLC	Half Year Results
Henry Boot PLC	Half Year Results
ITM Power PLC	Full Year Results
MaxCyte Inc	Half Year Results
MP Evans Group PLC	Half Year Results
Spectral MD Holdings Ltd	Half Year Results
S4 Capital PLC	Half Year Results
SThree PLC	Q3 Results
Surface Transforms PLC	Half Year Results
Verici Dx PLC	Half Year Results
Tuesday 14 September
accesso Technology Group PLC	Half Year Results
Bluejay Mining PLC	Half Year Results
British Honey Co PLC	Half Year Results
CloudCall Group PLC	Half Year Results
Diurnal Group PLC	Full Year Results
Equals Group PLC	Half Year Results
Filta Group Holdings PLC	Half Year Results
Good Energy Group PLC	Half Year Results
Harworth Group PLC	Half Year Results
JD Sports Fashion PLC	Half Year Results
Made.com Group PLC	Half Year Results
MJ Gleeson PLC	Full Year Results
NCC Group PLC	Full Year Results
Ocado Group PLC	Q3 Results
Ocean Outdoor Ltd	Half Year Results
Petra Diamonds Ltd	Full Year Results
Portmeirion Group PLC	Half Year Results
Property Franchise Group PLC	Half Year Results
Sanne Group PLC	Half Year Results
Smart Metering Systems PLC	Half Year Results
Staffline Group PLC	Half Year Results
STM Group PLC	Half Year Results
Team17 Group PLC	Half Year Results
Tern PLC	Half Year Results
ThinkSmart Ltd	Full Year Results
TP Group PLC	Half Year Results
Xaar PLC	Half Year Results

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

2 Dec 2019 13:19

Diurnal submits application for 'Alkindi Sprinkle' to US FDA

(Sharecast News) - Specialty pharmaceutical company Diurnal Group has submitted a 'New Drug Application' (NDA) to the US Food and Drug Administration (FDA), for the regulatory approval of 'Alkindi Sprinkle', or hydrocortisone granules in capsules for opening, as a replacement therapy of adrenal insufficiency in infants, children and adolescents in the US, it announced on Monday.

21 Nov 2019 11:36

Diurnal Primary Focus Remains On Progressing Flagship Products

20 Nov 2019 11:36

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

24 Sep 2019 11:21

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

14 Jun 2019 14:26

Diurnal Shareholders Approve Placing, Open Offer Worth GBP6 Million (ALLISS)

(Alliance News) - Pharmaceutical firm Diurnal Group PLC's shareholders on Friday approved its GBP5.9 million fundraise completed earlier in the day.Diurnal, which focuses on patients or

28 May 2019 13:32

Diurnal Group launches placing and open offer to fund drug development

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced a conditional placing of new ordinary shares in the company and the launch of an open offer on Tuesday, in order to raise funds to progress the development and commercialisation of its products.

28 May 2019 10:49

Diurnal Raises GBP5 Million Via Placing; Plans GBP1 Million Open Offer (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said Tuesday it has raised around GBP5.4 million via a 20.6 million share placing priced at 26 pence per share and announced an open offer to raise up to

10 May 2019 09:36

Polar Capital Global Healthcare Lags Behind Benchmark In First Half

LONDON (Alliance News) - Polar Capital Global Healthcare Trust PLC said on Friday it lagged against its benchmark for the first half of its financial year, as the healthcare trust underperformed a

24 Apr 2019 15:50

Diurnal gets orphan drug designation for Alkindi in Australia

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that its 'Alkindi' product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication 'replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old'.

24 Apr 2019 10:44

Diurnal Gets Orphan Drug Designation For Alkindi In Australia

LONDON (Alliance News) - Diurnal Group PLC on Wednesday said its adrenal insufficiency drug Alkindi has been granted a second patent and orphan drug designation in Australia.Shares in were

28 Mar 2019 08:35

Diurnal soars after securing Nordic distribution deal

(Sharecast News) - Diurnal's shares leapt on Thursday despite a widened interim loss as the company landed a marketing and distribution deal for its Alkindi treatment in Scandinavia.

21 Mar 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 22 March Sanne GroupFull Year ResultsSmiths GroupHalf Year BootFull Year

20 Mar 2019 10:33

Diurnal Group upbeat following FDA meeting over 'Alkindi'

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that, following a "positive" meeting with the US Food and Drug Administration (FDA), it intended to submit a new drug application (NDA) for 'Alkindi' (hydrocortisone granules in capsules for opening) in the fourth quarter of 2019 as previously planned, with final acceptance of the filing by the FDA expected in 2020.

25 Feb 2019 10:39

Diurnal expecting Israel launch of 'Alkindi' next year

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Monday that its marketing and distribution partner, Medison Pharma has successfully submitted a market authorisation application (MAA) for its 'Alkindi' (hydrocortisone granules in capsules for opening) product to the Ministry of Health in Israel.

10 Jan 2019 12:35

Diurnal Granted US Patent But Unsure Why Share Price Has Tripled

LONDON (Alliance News) - Diurnal Group PLC said on Thursday that, aside from the granting of a patent, it is unsure as to why its share price has tripled.Shares were 188% higher on Thursday

Latest Share Chat

DNL.L Share News (DNL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account